A rare disease is any condition that affects a small proportion of the population — commonly defined in the EU as fewer than 1 in 2,000 people — and in total the roughly 6,000–7,000 recognized rare diseases affect an estimated 3.5%–5.9% of people worldwide at some point in their lives. Collectively, rare diseases are not rare at all: a population-level analysis of the Orphanet database estimated a cumulative point prevalence consistent with roughly 260–450 million people affected globally [1][10].

The "diagnostic odyssey"

A hallmark of rare disease is the long delay between the first symptoms and an accurate diagnosis — often called the diagnostic odyssey. A EURORDIS survey of patients with eight rare diseases in Europe documented that many patients waited years, saw multiple specialists, and frequently received incorrect diagnoses along the way [2].

The odyssey is not just frustrating — it has real consequences. Delayed diagnosis can mean:

Missed opportunities for disease-modifying treatment
Unnecessary tests and procedures
Inappropriate or potentially harmful treatments based on an incorrect diagnosis
Genetic risk to relatives that goes unrecognized
Psychological burden on patients and families

Why genomic sequencing is changing this

Roughly 72% of rare diseases are thought to have a genetic basis, and many are caused by variants in single genes [1][10]. Over the past decade, the cost of DNA sequencing has fallen dramatically, making whole-exome and whole-genome sequencing increasingly accessible for clinical use.

A 2013 NEJM study reported that clinical whole-exome sequencing reached a molecular diagnosis in about 25% of patients referred for suspected mendelian disorders — a dramatic improvement over traditional testing in many categories [3]. More recently, the 100,000 Genomes Project in the UK published a preliminary report in NEJM showing that whole-genome sequencing delivered new diagnoses for 25% of participants with previously undiagnosed rare diseases, with important management changes in a substantial fraction [4].

Rapid genomic sequencing in critically ill infants

Some of the most striking results have come from studies in neonatal intensive care units. Rapid whole-genome sequencing — returning results in days — has demonstrated faster diagnosis, changes in clinical management, and in some studies reduced hospital costs compared to standard care [5]. A randomized trial published in the American Journal of Human Genetics compared singleton and trio rapid sequencing in ill infants, showing meaningful diagnostic yield and clinical utility [6].

What genetic testing can and cannot do

Genetic testing has real strengths and real limitations [7][9]:

Can identify disease-causing variants in well- understood genes, enabling precise diagnosis and in some cases disease-specific treatment
Can inform reproductive choices and identify at-risk family members
Can guide management, even when no disease- specific therapy exists, by clarifying prognosis and informing monitoring plans
Cannot always interpret variants of uncertain significance — genes whose role in disease is not yet clear
Cannot find a mutation that is not there, if the disease is caused by a mechanism current tests do not detect
May reveal incidental findings — variants unrelated to the original indication that have health implications, creating ethical and counseling challenges

The role of rare disease specialist networks

Even when a genetic diagnosis is made, care requires specialists familiar with the condition. Several dedicated networks exist to support diagnosis and care:

NIH Undiagnosed Diseases Network (UDN) — a consortium of US medical centers accepting referrals for patients whose diagnosis has not been reached despite extensive evaluation [8]
European Reference Networks (ERNs) — 24 thematic networks covering groups of rare and complex conditions, pooling specialist expertise across Europe
Orphanet — a comprehensive portal listing rare diseases, classifications, expert centers, and patient organizations [10]

Newborn screening

Many countries include screening for a panel of rare conditions in routine newborn screening — typically treatable metabolic and endocrine disorders where early detection significantly changes outcomes (e.g., congenital hypothyroidism, phenylketonuria, cystic fibrosis in some programs). The specific panel varies by country [9].

Treatment landscape

The rare disease treatment landscape has expanded significantly — from a handful of "orphan drugs" in the 1980s to hundreds today. Advances include enzyme replacement therapies, small molecules for cystic fibrosis (CFTR modulators), gene therapies, and RNA-targeted therapies. Even so, the majority of rare diseases still lack a disease-specific therapy, and supportive care remains the foundation of management for many conditions.

Frequently asked questions

How do I know if I should pursue genetic testing? Consider discussing genetic testing with a doctor or genetic counselor if you have an undiagnosed chronic condition with unusual features, multiple affected family members, a congenital anomaly, or a condition that started early in life without clear cause.

Is direct-to-consumer genetic testing the same thing? No. Direct-to-consumer tests (ancestry, wellness) are not equivalent to clinical diagnostic sequencing. For diagnosis of a rare disease, clinical testing ordered by a qualified clinician with a clear clinical question is what matters.

What if my test comes back negative? A negative result does not necessarily rule out a genetic disease. Science progresses, and re-analysis of older data years later sometimes yields a new answer [3][4].

Is genetic testing covered by insurance or the NHS? Coverage varies widely by country and condition. In many public systems, clinical genetic testing is funded when criteria are met; in others, it may require private payment. Ask your doctor or genetic counselor about local pathways.

When to talk to a doctor

Unexplained combinations of symptoms that multiple specialists have not been able to diagnose
A family history suggestive of an inherited condition
A child with congenital anomalies, developmental delay, or regression
A chronic symptom pattern that does not fit a common diagnosis
You are considering genetic testing and want guidance

A doctor on Heliodoc can help you organize your medical history, prepare for referrals to genetic or specialist services, and connect you with patient advocacy organizations when a diagnosis is suspected or recently confirmed.

Rare Diseases and the Diagnostic Odyssey: How Genetic Testing Is Changing Outcomes